MedPath

广西河丰药业有限责任公司

Ownership
-
Established
2000-09-18
Employees
-
Market Cap
-
Website
http://www.gxhfyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

69

NMPA:69

Drug Approvals

Estazolam Tablets

Product Name
艾司唑仑片
Approval Number
国药准字H45020751
Approval Date
May 22, 2021
NMPA

Tetrahydropal Matine Sulfate Injection

Product Name
鱼腥草注射液
Approval Number
国药准字Z45021073
Approval Date
Sep 29, 2020
NMPA

Hydroxylcamptothecine Injection

Product Name
羟喜树碱注射液
Approval Number
国药准字H45021213
Approval Date
Sep 28, 2020
NMPA

Tetrahydropal Matine Sulfate Injection

Product Name
硫酸四氢帕马丁注射液
Approval Number
国药准字H45021047
Approval Date
Sep 28, 2020
NMPA

Hydroxylcamptothecine Injection

Product Name
羟喜树碱注射液
Approval Number
国药准字H45021051
Approval Date
Sep 28, 2020
NMPA

Procaine Hydrochloride Injection

Product Name
盐酸普鲁卡因注射液
Approval Number
国药准字H45020755
Approval Date
Sep 27, 2020
NMPA

Procaine Hydrochloride Injection

Product Name
盐酸普鲁卡因注射液
Approval Number
国药准字H45020754
Approval Date
Sep 27, 2020
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H45020836
Approval Date
Sep 27, 2020
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H45020833
Approval Date
Sep 27, 2020
NMPA

Nefopam Hydrochloride Injection

Product Name
盐酸奈福泮注射液
Approval Number
国药准字H45020065
Approval Date
Sep 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.